FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes agent that possesses the nootropic activity and comprises dimephosphone as an active substance. Medicinal agent in form of an aqueous solution comprises additionally citric acid and lithium carbonate in the following ratio of components, wt.-%: dimephosphone, 15.0-30.0; lithium carbonate, 0.5-5.0; citric acid, 3.0-4.0, and deionized water, up to 100. Medicinal agent in form of syrup comprises the following composition, wt.-%: dimephosphone, 3.0-5.0; lithium carbonate, 1.0-1.2; citric acid, 4.0-5.0, and 64% sugar syrup, 89.0-92.0. Variants of the invention are syrup with the increased concentration of dimephosphone, and syrup comprising glycine additionally. Novel medicinal agents show physiological pH values elicited in the broad range of concentrations, stability of solutions in dilution, pleasant taste that simplified their using in pediatrics.
EFFECT: improved and valuable pharmaceutical properties of drug.
5 cl, 5 tbl, 1 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
GAMMA-AMINOBUTYRIC ACID DERIVATIVE, HAVING NOOTROPIC ACTIVITY COUPLED WITH TRANQUILISING ACTIVITY | 2012 |
|
RU2495866C1 |
WATER-SOLUBLE SALICYL MORPHOLIDE POSSESSING NOOTROPIC ACTIVITY IN COMBINATION WITH ANTIDEPRESSANT ACTION | 2012 |
|
RU2495032C1 |
N-(4-ACETOXYBENZOYL)GLYCINE LITHIUM SALT POSSESSING TRANQUILISING AND NOOTROPIC ACTION | 2012 |
|
RU2505294C1 |
MEDICINE COMPOSITION, POSSESSING NOOTROPIC ACTIVITY | 2007 |
|
RU2331432C1 |
DERIVATIVE OF 3-HYDROXYPYRIDINE WITH ANXIOLYTIC AND NOOTROPIC EFFECT | 2017 |
|
RU2664453C1 |
METHOD OF CORRECTING INTELLECTUAL-MNESTIC FUNCTIONS IN INFANTS SUFFERING FROM RETARDED PSYCHIC DEVELOPMENT | 1991 |
|
RU2020938C1 |
PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
COMPOSITION HAVING ACTION ON CENTRAL NERVOUS SYSTEM AND USING IT | 2013 |
|
RU2546300C1 |
QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
Authors
Dates
2008-04-20—Published
2006-07-05—Filed